SynthesisMolecular biology reports2025
Spirulina supplementation and rheumatoid arthritis: A systematic review of current research and molecular mechanisms.
Synthesis in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural products have gained popularity as adjuvant therapies for managing degenerative diseases, including rheumatoid arthritis (RA). Preclinical studies suggest the beneficial effects of Spirulina in RA; however, there no systematic review is available. To address this gap, we conducted a systematic review of the existing evidence on the role of Spirulina in RA. A comprehensive Literature search was conducted in Scopus, Web of Science, PubMed, and Google Scholar up to April 2025. Search alert services were employed to identify newly published articles after the initial search. Both MeSH terms and text words were applied, with no restrictions on language or publication date. Two independent researchers performed the search and screening. Ultimately, 13 animal studies met the inclusion criteria, while no eligible human or in vitro studies were identified. The included studies indicated that Spirulina may confer protective effects against RA through multiple mechanisms. These include inhibition of cyclooxygenase-2, lipoxygenase, and myeloperoxidase enzymes activity; suppression of pro-inflammatory cytokines production; inhibition of angiogenesis; scavenging of free radicals; and enhancement of both enzymatic and non-enzymatic antioxidant activity. Evidence from animal studies supports the potential therapeutic role of Spirulina in RA. Nonetheless, well-designed clinical trials and in vitro studies are needed to clarify its mechanisms of action, establish optimal dosing, and evaluate safety and long-term efficacy in human populations.
Indexed as
Identifiers
40960533What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.